Community pharmacies receive ‘fairer’ funding in annual settlement Community Pharmacy Scotland said community pharmacies will receive a £8.5m uplift to the global sum, as well as an £10m increase to the guaranteed minimum reimbursement in 2026/2027.…
PDA gains full say on NHS pay and conditions negotiations after joining Staff Side Council The Pharmacists’ Defence Association said that it can now vote on the staff side's position on issues specific to pharmacists as one of a group of 14 unions, which represent over 1 million NHS employees.…
Parliamentary committees ask National Audit Office to look at UK–US pharmaceuticals deal In a letter to the NAO, the chairs of six House of Commons committees requested a “rapid investigation” into the costs and potential long-term implications of the UK–US pharmaceuticals deal.…
Breast cancer drug Enhertu recommended for NHS use 'Milestone victory belongs to every person who refused to accept that access to a life-extending treatment was out of reach' says charity leader.…
Large areas of England do not commission enough childhood asthma tests Research by charity Asthma + Lung UK found that 35% of integrated care systems did not have a dedicated respiratory clinical lead for children and young people.…
Pharmacist training sites to receive backdated funding uplift NHS England said that for the 2026/2027 academic year, eligible pharmacist training sites will receive a 3.3% increase in funding per trainee compared with 2025/2026.…
Moving from conversation to action on women’s health ‘Menopause, unmissed’ takes a holistic approach to improving women’s health outcomes, demonstrating the potential of effective cross-sector collaboration.…
Alex Williams: ‘There’s a risk to the resilience of the supply chain if government doesn’t invest’ Increased costs and low medicines reimbursement could jeopardise the service that wholesalers provide to pharmacies, says the new chief executive of the Healthcare Distribution Association.…
Short-term savings, long-term costs: what cuts to medicines optimisation teams could mean for the NHS Integrated care boards have confirmed to The Pharmaceutical Journal that they are reducing headcount in their medicines optimisation teams, which are primarily formed of pharmacists. What will this mean for the future NHS?…
Government ‘missing huge trick’ excluding pharmacies from NHS capital investment plan, say leaders Pharmacy organisation leaders have said the exclusion of pharmacy from the NHS capital investment plan could hinder the expansion of services where patients need them.…
